GRAIL to Present at the 44th Annual J.P. Morgan Healthcare Conference
GRAIL (Nasdaq: GRAL) announced management will present at the 44th Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
GRAIL (Nasdaq: GRAL) announced management will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, Jan. 12, 2026 at 7:30 a.m. PT. Live and replay webcasts will be available in the investor relations section at investors.grail.com. The webcast will be archived and available for replay for at least 30 days after the event.
Details
News Market Reaction – GRAL
On Dec 16, the first trading day after this news, GRAL closed 4.42% below the previous close.
Data tracked by StockTitan Argus for the Dec 16 session.
Key Figures
- Conference edition
- 44th
- 44th Annual J.P. Morgan Healthcare Conference
- Presentation time
- 7:30 a.m. PT
- Scheduled presentation on Monday, Jan. 12
- Webcast archive period
- 30 days
- Replay available for at least 30 days after event
Historical Context
-
Inducement RSU grants to 21 non-executive employees totaling 21,570 shares.
-
Announcement of management presentation at Piper Sandler healthcare conference.
-
Q3 2025 revenue growth, narrowed losses, financings, and extended cash runway.
-
Management presentation at Wolfe Research healthcare conference with webcast access.
-
Scheduled Q3 2025 results release and Analyst Day webcast details.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Live and replay webcasts may be accessed in the investor relations section of GRAIL's website at investors.grail.com. The webcast will be archived and available for reply for at least 30 days after the event.
About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in
For more information, visit grail.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-to-present-at-the-44th-annual-jp-morgan-healthcare-conference-302642502.html
SOURCE GRAIL, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.